Trial Profile
Reversing the Effects of 0.5% Bupivacaine: A Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Jan 2020
Price :
$35
*
At a glance
- Drugs Phentolamine (Primary) ; Bupivacaine/epinephrine
- Indications Anaesthesia
- Focus Therapeutic Use
- 28 Jan 2020 Primary endpoint (Return of normal sensation: mean difference for smiling, drinking and speaking) has not been met, according to results published in the Journal of Clinical Pharmacology
- 28 Jan 2020 Primary endpoint (Return of normal sensation: mean difference for lower lip and tongue) has been met, according to results published in the Journal of Clinical Pharmacology
- 28 Jan 2020 Results published in the Journal of Clinical Pharmacology